PAL-222

· PharmaBio Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PAL-222, covering 2025-06-11 to 2025-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA) [NA]